Ling Gao

7PUBLICATIONS
16CO-AUTHORS
Gene expression (incl. microarray and other genome-wide approaches)Pharmaceutical delivery technologiesPredictive and prognostic markersMolecular targetsMedical devices
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Feb 19, 2026
Revitalizing GIP: Therapeutic Potential in Metabolic and Neurodegenerative Disorders.

Yingdan Qiao, Fen Zhou, Tuohua Mao

|Oct 14, 2025
Triple oral therapy with metformin, DPP-4 inhibitor, and SGLT2 inhibitor for adults with type 2 diabetes: Consensus recommendations of a Chinese expert panel (version 2025).

Miao Yu, Tong Wang, Chun Xu

|Apr 24, 2024
The predictive value of plasma uridine for type 2 diabetes and its atherosclerotic complications.

Yueyuan Yang, Tingting Yu, Zhili Niu

|Jan 11, 2023
Perspective of SGLT2i in the Treatment of Abdominal Aortic Aneurysms.

Zhongtiao Jin, Hongping Deng, Sizheng Xiong

|Jul 09, 2020
The impact of type 2 diabetes and its management on the prognosis of patients with severe COVID-19.

Zihui Xu, Zhongjing Wang, Shuo Wang

|Dec 31, 2019
YAP Levels Combined with Plasma CEA Levels Are Prognostic Biomarkers for Early-Clinical-Stage Patients of Colorectal Cancer.

Zihui Xu, Hui Wang, Ling Gao

Pageof 2

Frequent Collaborators

1 joint publications

Xiaoxing Xiong

1 joint publications

Xiangyang Wang

1 joint publications

Zihui Xu

1 joint publications

Zhongjing Wang